Biodistribution and stability studies of [18F]Fluoroethylrhodamine B, a potential PET myocardial perfusion agent

Nuclear Medicine and Biology

Volumn 37, Issue 3, 2010, Pages 365-370

  Gottumukkala, Vijay ^a,b   Heinrich, Tobias K ^a,b,c   Baker, Amanda ^a   Dunning, Patricia ^a   Fahey, Frederic H ^a,b   Treves, S Ted ^a,b   Packard, Alan B ^a,b  

^a BOSTON CHILDREN S HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c Bayer Schering Pharma   (Germany)

Author keywords

Fluorine 18; Myocardial perfusion imaging; Positron emission tomography; Rhodamine B

Indexed keywords

FLUOROETHYLRHODAMINE B F 18; PHOSPHATE BUFFERED SALINE; RADIOISOTOPE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BLOOD ANALYSIS; CONTROLLED STUDY; HEART MUSCLE PERFUSION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; IN VITRO STUDY; ISOTOPE ANALYSIS; ISOTOPE TRACING; MALE; MOLECULAR STABILITY; MOUSE; NONHUMAN; POSITRON EMISSION TOMOGRAPHY; RADIOISOTOPE DISTRIBUTION; RAT; SPECIES COMPARISON; TISSUE DISTRIBUTION;

ANIMALS; FEASIBILITY STUDIES; FLUORINE RADIOISOTOPES; HEART; HUMANS; METABOLIC CLEARANCE RATE; MICE; MYOCARDIAL PERFUSION IMAGING; MYOCARDIUM; ORGAN SPECIFICITY; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS; RATS; RHODAMINES; SPECIES SPECIFICITY; TISSUE DISTRIBUTION;

EID: 77950298585     PISSN: 09698051     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nucmedbio.2009.12.005     Document Type: Article

References (32)

1. Higuchi T., Bengel F.M. Cardiovascular nuclear imaging: from perfusion to molecular function. Heart 2008, 94:809-816.
2. Beller G.A., Watson D.D. A welcomed new myocardial perfusion imaging agent for positron emission tomography. Circulation 2009, 119:2299-2301.
3. 18F-labeled potential myocardial blood flow tracers. Nuc Med Biol 2001, 28:683-693.
4. 18F]fluorobenzyl triarylphosphonium ions. J Labelled Comp Radiopharm 2004, 47:469-476.
5. 18F-fluorobenzyl triphenyl phosphonium in dog myocardium. J Nucl Med 2006, 47:1359-1366.
6. 99mTc-tetrofosmin. J Nucl Med 2007, 48:1021-1030.
7. 18F-Fluorobenzyltriphenyl phosphonium PET detects area-specific apoptosis in the aging myocardium. Society of Nuclear Medicine, 54th Annual Meeting. Washington, DC 2007, 166P.
8. 18F]fluorophenyl)triphenylphosphonium ion as a potential myocardial blood flow agent for PET 2005, 62P.
9. 201Tl. J Nucl Med 2004, 45:1950-1959.
10. 18F-labeled myocardial perfusion tracer. J Nucl Med 2008, 49:630-636.
11. Yalamanchili P., Wexler E., Hayes M., Yu M., Bozek J., Kagan M., et al. Mechanism of uptake and retention of F-18 BMS-747158-02 in cardiomyocytes: a novel PET myocardial imaging agent. J Nucl Cardiol 2007, 14:782-788.
12. Yu M., Guaraldi M.T., Mistry M., Kagan M., McDonald J.L., Drew K., et al. BMS-747158-02: a novel PET myocardial perfusion imaging agent. J Nucl Cardiol 2007, 14:789-798.
13. Purohit A., Radeke H., Azure M., Hanson K., Benetti R., Su F., et al. Synthesis and biological evaluation of pyridazinone analogues as potential cardiac positron emission tomography tracers. J Med Chem 2008, 51:2954-2970.
14. 18F-labeled rhodamine B derivatives for myocardial perfusion imaging with PET 2007.
15. 18F-labeled rhodamine B: a potential PET myocardial perfusion agent. Society of Nuclear Medicine, 55th Annual Meeting. New Orleans, LA 2008, 302P.
16. Heinrich T.K., Gottumukkala V., Snay E., Dunning P., Fahey F.H., Treves S.T., et al. Synthesis of fluorine-18 labeled rhodamine B: a potential PET myocardial perfusion imaging agent. Appl Radiat Isot 2010, 68:96-100.
17. Gottumukkala V., Heinrich T.K., Treves S.T., Packard A.B. Serum stability studies of F-18-ethyl-rhodamine B. J Labelled Comp Radiopharm 2009, 52(Suppl. 1):S110.
18. Lacerda S.H., Abraham B., Stringfellow T.C., Indig G.L. Photophysical, photochemical, and tumor-selectivity properties of bromine derivatives of rhodamine-123. Photochem Photobiol 2005, 81:1430-1438.
19. Reungpatthanaphong P., Dechsupa S., Meesungnoen J., Loetchutinat C., Mankhetkorn S. Rhodamine B as a mitochondrial probe for measurement and monitoring of mitochondrial membrane potential in drug-sensitive and -resistant cells. J Biochem Biophys Methods 2003, 57:1-16.
20. Hu Y., Moraes C.T., Savaraj N., Priebe W., Lampidis T.J. Rho(0) tumor cells: a model for studying whether mitochondria are targets for rhodamine 123, doxorubicin, and other drugs. Biochem Pharmacol 2000, 60:1897-1905.
21. Lampidis T.J., Hasin Y., Weiss M.J., Chen L.B. Selective killing of carcinoma cells "in vitro" by lipophilic-cationic compounds: a cellular basis. Biomed Pharmacother 1985, 39:220-226.
22. Rusiecka I., Skladanowski A.C. Induction of the multixenobiotic/multidrug resistance system in various cell lines in response to perfluorinated carboxylic acids. Acta Biochim Pol 2008, 55:329-337.
23. De Moerloose B., Van de Wiele C., Dhooge C., Philippe J., Speleman F., Benoit Y., et al. Technetium-99m sestamibi imaging in paediatric neuroblastoma and ganglioneuroma and its relation to P-glycoprotein. Eur J Nucl Med 1999, 26:396-403.
24. Vora M.M., Dhalla M. In vivo studies of unlabeled and radioiodinated rhodamine-123. Nuc Med Biol 1992, 19:405-410.
25. Kronauge J.F., Noska M.A., Davison A., Holman B.L., Jones A.G. Interspecies variation in biodistribution of technetium (2-carbomethoxy- 2-isocyanopropane)6+. J Nucl Med 1992, 33:1357-1365.
26. Smart B.E. Characteristics of C-F systems. Organofluorine chemistry: principles and commercial applications 1994, 68. Plenum Press, New York. R.E. Banks, B.E. Smart, J.C. Tatlow (Eds.).
27. 18F-FECNT: a polar radiometabolite confounds brain radioligand measurements. J Nucl Med 2006, 47:520-527.
28. Tewson T.J., Welch M.J. Preparation and preliminary biodistribution of "no carrier added" fluorine-18 fluoroethanol. J Nucl Med 1980, 21:559-564.
29. 99mTc]hexakis(2-methoxyisobutylisonitrile). J Med Chem 1998, 41:2111-2117.
30. Palestro C.J., Tomas M.B., Tronco G.G. Radionuclide imaging of the parathyroid glands. Semin Nucl Med 2005, 35:266-276.
31. López Arbeloa I., Ruiz Ojeda P. Dimeric states of rhodamine B. Chem Phys Lett 1982, 87:556-560.
32. Martarello L., Greenamyre J.T., Goodman M.M. Synthesis and evaluation of a new fluorine-18 labeled rotenoid as a potential PET probe of mitochondrial complex I activity. J Labelled Comp Radiopharm 1999, 42:1039-1051.